Zenabis to Supply Premium Recreational Cannabis to Alberta
Becomes eighth province/territory for Zenabis products
VANCOUVER, Feb. 20, 2019 /CNW/ – Zenabis Global Inc. (“Zenabis”) (TSXV: ZENA) today announced that it will formally enter the Alberta recreational cannabis market, supplying retailers throughout the province through a Supply Agreement it has entered into with the Alberta Gaming, Liquor & Cannabis Commission (AGLC). Zenabis will supply seven strains of its premium, adult-use Namastetm products beginning Q1 2019.
Alberta represents the eighth province/territory that Zenabis will supply, and builds on Zenabis’ significant recent momentum in developing sales and marketing channels for its complete range of products. On February 4, 2019 Zenabis announced an agreement with Shoppers Drug Mart, adding a major new retail channel to serve medical patients across Canada.
We are thrilled to offer our products to Alberta consumers, and to grow our distribution platform in a significant new market. We look forward to continuing the rapid expansion of our distribution relationships in Canada and abroad.
Andrew Grieve, Chief Executive Officer of Zenabis
In addition to Alberta, Zenabis has distribution relationships with government and third-party retailers/distributors British Columbia, Saskatchewan, Manitoba, New Brunswick, Nova Scotia, Prince Edward Island, and the Yukon Territory.
About Zenabis
Zenabis is a significant licensed cannabis cultivator of medical and recreational cannabis, and employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Delta and Langley, B.C.; and Stellarton, Nova Scotia. Zenabis currently owns 3.5 million square feet of facility space that can, upon full conversion, be dedicated to cannabis production.
If all facility space is fully built out and dedicated to production, Zenabis will own, and have access to, 660,000 square feet of high quality indoor cannabis production space, as well as 2.1 million square feet of greenhouse space at its Langley facility that is intended to be dedicated to cannabis production, with this cannabis production capacity strategically located on Canada’s East and West coasts. These facilities, if fully converted for cannabis production, would have the design capacity to yield 479,300kg of dried cannabis annually, for both national and international market distribution. An additional 700,000 square feet of greenhouse space will be used to continue the existing propagation business, and this will be converted at such a time that is beneficial to the strategic position of the company. The Zenabis brand name is used among the medical market, while Namaste is used to service the recreational market.
The management team at Zenabis has significant experience in finance, agriculture, technology, pharmaceutical sales, consumer packaged goods, international distribution and brand marketing. Zenabis’ leadership is backed by the expertise of a Chief Operating Officer, Chief Growing Officer, a Chief Science Officer and Chief Medical Officer.
